You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
NEW YORK – Foundation Medicine announced Friday its collaboration with Takeda Pharmaceuticals USA to develop Foundation's companion diagnostics for use with Takeda's lung cancer portfolio.
Financial and other terms of the deal were not disclosed.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.